Home Tags Medicines

Tag: Medicines

Business

Everest Medicines Announces the Acceptance and Priority Review of VELSIPITY(R) Manufacturing Localization Application by the Center for Drug Evaluation of China’s NMPA, Driving Continued Commercial Momentum

Leslie Atkins -
0
Business

Everest Medicines Announces Close of Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib

Correspondent -
0
Business

Everest Medicines Announces NMPA Acceptance of the BLA for LEROCHOL(R), Offering a Potential New Treatment Option for Hypercholesterolemia in China

Correspondent -
0
Business

Everest Medicines Enters into Exclusive Licensing Agreement with Dimerix for DMX-200 in Greater China, South Korea and Southeast Asia

Leslie Atkins -
0
Business

Everest Medicines Secures Exclusive License for Sumecigrel in Asia-Pacific, Expanding Its Cardiovascular Product Portfolio

Leslie Atkins -
0
Business

Everest Medicines Enters into Asset Purchase Agreement with Corxel Pharmaceuticals to Develop and Commercialize LNZ100 in Greater China, Strengthen Presence in Ophthalmology

Leslie Atkins -
0
Business

Everest Medicines Enters Commercialization License Agreement with Mabworks for Bejescin(R) in the Asia-Pacific Market

Editor -
0
Business

Everest Medicines Enters into Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib a Potential Best-in-Class BTK Inhibitor for Rare Kidney Diseases, Driving Value Conversion

Editor -
0
Business

Everest Medicines Receives Shareholding Increase from Substantial Shareholder CBC Group, Global Expansion Expected to Benefit

Editor -
0
Business

Everest Medicines Acquires Exclusive Greater China and Other Asian Country Rights to VIS-101, a Novel Bifunctional Biologic for Serious Eye Disorders

Editor -
0
Business

Everest Medicines Announces First Patient Enrolled in a Global Multi-Center Phase I Clinical Trial of Tumor-Associated Antigen Cancer Vaccine EVM14

Leslie Atkins -
0
Business

Everest Medicines Announces 2025 Interim Results: ‘Dual-Engine’ Strategy Driving Strong Synergies Between Commercialization and R&D

Editor -
0
Business

Everest Medicines’ New Drug Application for Etrasimod Accepted in Taiwan, Marking Another Milestone in Asia Market Access

Leslie Atkins -
0
Business

Everest Medicines Announces Full Approval of NEFECON(R) in Taiwan

Correspondent -
0
Business

Everest Medicines Expands Strategic Investment in I-MAB to Advance the Global Value of Its Proprietary Next-Generation Cancer Immunotherapies

Editor -
0
Business

Everest Medicines Unveils Breakthroughs in AI+mRNA Platform, Reinforces Global Leadership in Next-Gen mRNA Innovation

Editor -
0
Business

Everest Medicines Announces the First Prescription of VELSIPITY(R) in the Greater Bay Area

Editor -
0
Business

Everest Medicines Announces NEFECON(R)’s Full Approval in South Korea

Correspondent -
0
Business

Everest Medicines Announces Taiwan TFDA Approval of NEFECON for the Treatment of Primary IgA Nephropathy

Editor -
0
Business

Everest Medicines’ Stock Price Rises by 20% as Profit Potential Drives Valuation Recovery

Editor -
0
Business

Kingworld Medicines Expects 1H Profit Increased By 35%-40%

-
0
Business

European Medicines Agency Accepts Astellas’ Marketing Authorization Application for Zolbetuximab

-
0
Get $10 by answering a Simple Survey. Click Here